ConductScience.org, home

Paper29460740

Ending the HIV/AIDS Pandemic1.

Eisinger RW and 1 other. Emerg Infect Dis, 2018. Cited by 110 papers, by iCite.

Cite this record

ConductScience Library. Ending the HIV/AIDS Pandemic1. Papers, record 29460740. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29460740

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ending the HIV/AIDS Pandemic1.
PubMed
Journal
Emerg Infect Dis
PubMed
Year
2018
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
110
iCite
Relative citation ratio, by iCite
4.59
iCite
Revised in PubMed
2019-01-16
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Eisinger RWRobert Walter
2Fauci ASAnthony S

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acquired Immunodeficiency SyndromeMajor topic
HIV InfectionsMajor topic
Global Health
Humans
Pandemics

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129020235Redefining Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis Failures.Clin Infect Dis2017https://conductscience.org/library/papers/29020235PubMed
222784038Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.N Engl J Med2012https://conductscience.org/library/papers/22784038PubMed
322784037Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.N Engl J Med2012https://conductscience.org/library/papers/22784037PubMed
46200936Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.Science1984https://conductscience.org/library/papers/6200936PubMed
528368868Universal antiretroviral regimens: thinking beyond one-pill-once-a-day.Curr Opin HIV AIDS2017https://conductscience.org/library/papers/28368868PubMed
623769234Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.Lancet2013https://conductscience.org/library/papers/23769234PubMed
76265753Pneumocystis pneumonia--Los Angeles.MMWR Morb Mortal Wkly Rep1981https://conductscience.org/library/papers/6265753PubMed
829052689An HIV Vaccine Is Essential for Ending the HIV/AIDS Pandemic.JAMA2017https://conductscience.org/library/papers/29052689PubMed
96789108Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California.MMWR Morb Mortal Wkly Rep1981https://conductscience.org/library/papers/6789108PubMed
1021767103Prevention of HIV-1 infection with early antiretroviral therapy.N Engl J Med2011https://conductscience.org/library/papers/21767103PubMed
1121091279Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.N Engl J Med2010https://conductscience.org/library/papers/21091279PubMed
1227404185Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.JAMA2016https://conductscience.org/library/papers/27404185PubMed
132874559190-90-90 and ending AIDS: necessary and feasible.Lancet2017https://conductscience.org/library/papers/28745591PubMed
1426624554Ending the HIV-AIDS Pandemic--Follow the Science.N Engl J Med2015https://conductscience.org/library/papers/26624554PubMed
156189183Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).Science1983https://conductscience.org/library/papers/6189183PubMed
1614600512Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world.AIDS2003https://conductscience.org/library/papers/14600512PubMed
1727424812Antiretroviral Therapy for the Prevention of HIV-1 Transmission.N Engl J Med2016https://conductscience.org/library/papers/27424812PubMed
188320787The lifetime cost of treating a person with HIV.JAMA1993https://conductscience.org/library/papers/8320787PubMed
193500409Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City.N Engl J Med1987https://conductscience.org/library/papers/3500409PubMed
2027028501Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care.J Acquir Immune Defic Syndr2016https://conductscience.org/library/papers/27028501PubMed

Download CSV of references

Cited by80

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 110 citations.

PMIDTitleJournalYearIn PapersSource
42201480Beliefs About Toxic Interactions Between Alcohol and PrEP Predict Less Initiation and More Discontinuation: Results from the RADAR Cohort Study.AIDS Behav2026https://conductscience.org/library/papers/42201480PubMed
41858071Characterizing AIDS Drug Assistance Program Practices and Policies for Sustained Viral Suppression Using the Consolidated Framework for Implementation Research: Protocol for a Qualitative Study.JMIR Res Protoc2026https://conductscience.org/library/papers/41858071PubMed
41796803Decoding the glycan shield: Immune recognition and response to the HIV-1 envelope trimer.J Biol Chem2026https://conductscience.org/library/papers/41796803PubMed
41687101The Potential Impact of Federal Funding Cuts on Access to Pre-Exposure Prophylaxis in Atlanta, Georgia: Geographic Modeling Study.JMIR Public Health Surveill2026https://conductscience.org/library/papers/41687101PubMed
40725935Determinants of virological failure among people living with HIV receiving first-line antiretroviral therapy in Hiwot Fana Comprehensive University Hospital, Eastern Ethiopia.Medicine (Baltimore)2025https://conductscience.org/library/papers/40725935PubMed
40699096The elimination of HIV/AIDS depends on prevention and treatment strategies that address health inequalities.Cad Saude Publica2025https://conductscience.org/library/papers/40699096PubMed
40573348Biomedical Interventions for HIV Prevention and Control: Beyond Vaccination.Viruses2025https://conductscience.org/library/papers/40573348PubMed
40192040Molecular Docking Studies of Scutellaria baicalensis Targeting HIV Co-Receptor CXCR4.Curr HIV Res2025https://conductscience.org/library/papers/40192040PubMed
40163070Strengthening the US Health Workforce to End the HIV Epidemic: Lessons Learned From 11 Ending the HIV Epidemic Jurisdictions.J Acquir Immune Defic Syndr2025https://conductscience.org/library/papers/40163070PubMed
40143346Structural Virology: The Key Determinants in Development of Antiviral Therapeutics.Viruses2025https://conductscience.org/library/papers/40143346PubMed
40134669Applying the Social Ecological Model to Explore HIV-Related Stigma in Florida: A Qualitative Study.Stigma Health2024https://conductscience.org/library/papers/40134669PubMed
40018594Low effective coverage of HIV testing and counselling services during antenatal care in Ethiopia: evidence from the demographic and health survey and service provision assessment.BMJ Public Health2024https://conductscience.org/library/papers/40018594PubMed
38983264Investigating the effects of cytokine biomarkers on HIV incidence: a case study for individuals randomized to pre-exposure prophylaxis vs. control.Front Public Health2024https://conductscience.org/library/papers/38983264PubMed
38969530Advancing Toward a Human Immunodeficiency Virus Cure: Initial Progress on a Difficult Path.Infect Dis Clin North Am2024https://conductscience.org/library/papers/38969530PubMed
38932203The Use of Broadly Neutralizing Antibodies (bNAbs) in HIV-1 Treatment and Prevention.Viruses2024https://conductscience.org/library/papers/38932203PubMed
38771971Barriers and facilitators to implementing evidence-based integrated HIV and behavioral health care: perspectives from seven federal ending the HIV epidemic jurisdictions.AIDS Care2024https://conductscience.org/library/papers/38771971PubMed
38662280
Empirical Development of a Behavioral Intervention for African American/Black and Latino Persons with Unsuppressed HIV Viral Load Levels: An Application of the Multiphase Optimization Strategy (MOST) Using Cost-Effectiveness as an Optimization Objective.
AIDS Behav2024https://conductscience.org/library/papers/38662280PubMed
38572241Inhibition of HIV-1 release by ADAM metalloproteinase inhibitors.Front Microbiol2024https://conductscience.org/library/papers/38572241PubMed
38500968Unlocking the potential of telehealth in Africa for HIV: opportunities, challenges, and pathways to equitable healthcare delivery.Front Digit Health2024https://conductscience.org/library/papers/38500968PubMed
38385642Tailoring Tfh profiles enhances antibody persistence to a clade C HIV-1 vaccine in rhesus macaques.Elife2024https://conductscience.org/library/papers/38385642PubMed

See all 80 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29460740

GET https://conductscience.org/api/papers/v1/29460740/cited_by?page=2